162 related articles for article (PubMed ID: 35734473)
1. Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease.
Kim Y; Rebman AW; Johnson TP; Wang H; Yang T; Colantuoni C; Bhargava P; Levy M; Calabresi PA; Aucott JN; Soloski MJ; Darrah E
Front Neurol; 2022; 13():874211. PubMed ID: 35734473
[TBL] [Abstract][Full Text] [Related]
2. PAD2-Mediated Citrullination Contributes to Efficient Oligodendrocyte Differentiation and Myelination.
Falcão AM; Meijer M; Scaglione A; Rinwa P; Agirre E; Liang J; Larsen SC; Heskol A; Frawley R; Klingener M; Varas-Godoy M; Raposo AASF; Ernfors P; Castro DS; Nielsen ML; Casaccia P; Castelo-Branco G
Cell Rep; 2019 Apr; 27(4):1090-1102.e10. PubMed ID: 31018126
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
Front Immunol; 2018; 9():2696. PubMed ID: 30515171
[No Abstract] [Full Text] [Related]
4. Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis.
Engström M; Eriksson K; Lee L; Hermansson M; Johansson A; Nicholas AP; Gerasimcik N; Lundberg K; Klareskog L; Catrina AI; Yucel-Lindberg T
J Transl Med; 2018 Jul; 16(1):214. PubMed ID: 30064459
[TBL] [Abstract][Full Text] [Related]
5. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
Damgaard D; Senolt L; Nielsen CH
Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
[TBL] [Abstract][Full Text] [Related]
8. Generation of monoclonal antibodies against peptidylarginine deiminase 2 (PAD2) and development of a PAD2-specific enzyme-linked immunosorbent assay.
Damgaard D; Palarasah Y; Skjødt K; Catrina AI; Hensen SM; Pruijn GJ; Nielsen CH
J Immunol Methods; 2014 Mar; 405():15-22. PubMed ID: 24384061
[TBL] [Abstract][Full Text] [Related]
9. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice.
Raijmakers R; Vogelzangs J; Raats J; Panzenbeck M; Corby M; Jiang H; Thibodeau M; Haynes N; van Venrooij WJ; Pruijn GJ; Werneburg B
J Comp Neurol; 2006 Sep; 498(2):217-26. PubMed ID: 16856138
[TBL] [Abstract][Full Text] [Related]
11. Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.
Horibata S; Rogers KE; Sadegh D; Anguish LJ; McElwee JL; Shah P; Thompson PR; Coonrod SA
BMC Cancer; 2017 May; 17(1):378. PubMed ID: 28549415
[TBL] [Abstract][Full Text] [Related]
12. Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood.
Calabrese R; Zampieri M; Mechelli R; Annibali V; Guastafierro T; Ciccarone F; Coarelli G; Umeton R; Salvetti M; Caiafa P
Mult Scler; 2012 Mar; 18(3):299-304. PubMed ID: 21878453
[TBL] [Abstract][Full Text] [Related]
13. Peptidylarginine Deiminase 2 in Host Immunity: Current Insights and Perspectives.
Wu Z; Li P; Tian Y; Ouyang W; Ho JW; Alam HB; Li Y
Front Immunol; 2021; 12():761946. PubMed ID: 34804050
[TBL] [Abstract][Full Text] [Related]
14. Serum Anti-oligodendrocyte Autoantibodies in Patients With Multiple Sclerosis Detected by a Tissue-Based Immunofluorescence Assay.
Miyachi Y; Fujii T; Yamasaki R; Tsuchimoto D; Iinuma K; Sakoda A; Fukumoto S; Matsushita T; Masaki K; Isobe N; Nakabeppu Y; Kira JI
Front Neurol; 2021; 12():681980. PubMed ID: 34421790
[TBL] [Abstract][Full Text] [Related]
15. Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain.
Shimada N; Handa S; Uchida Y; Fukuda M; Maruyama N; Asaga H; Choi EK; Lee J; Ishigami A
J Neurosci Res; 2010 Mar; 88(4):798-806. PubMed ID: 19830834
[TBL] [Abstract][Full Text] [Related]
16. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
17. Potential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones.
Cherrington BD; Morency E; Struble AM; Coonrod SA; Wakshlag JJ
PLoS One; 2010 Jul; 5(7):e11768. PubMed ID: 20668670
[TBL] [Abstract][Full Text] [Related]
18. PAD2: A potential target for tumor therapy.
Teng Y; Chen Y; Tang X; Wang S; Yin K
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188931. PubMed ID: 37315720
[TBL] [Abstract][Full Text] [Related]
19. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
Ishigami A; Ohsawa T; Hiratsuka M; Taguchi H; Kobayashi S; Saito Y; Murayama S; Asaga H; Toda T; Kimura N; Maruyama N
J Neurosci Res; 2005 Apr; 80(1):120-8. PubMed ID: 15704193
[TBL] [Abstract][Full Text] [Related]
20. Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning.
Badillo-Soto MA; Rodríguez-Rodríguez M; Pérez-Pérez ME; Daza-Benitez L; Bollain-Y-Goytia JJ; Carrillo-Jiménez MA; Avalos-Díaz E; Herrera-Esparza R
Eur J Rheumatol; 2016 Jun; 3(2):44-49. PubMed ID: 27708970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
